Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction-Reference-Cited by-同舟云学术

Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

Published:2006-08-20 Issue:10 Volume:12 Page:1198-1202
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Trautmann Lydie,Janbazian Loury,Chomont Nicolas,Said Elias A,Gimmig Sylvain,Bessette Benoit,Boulassel Mohamed-Rachid,Delwart Eric,Sepulveda Homero,Balderas Robert S,Routy Jean-Pierre,Haddad Elias K,Sekaly Rafick-Pierre

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm1482.pdf

Reference29 articles.

1. Chen, L. Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity. Nat. Rev. Immunol. 4, 336–347 (2004).

2. Ishida, Y., Agata, Y., Shibahara, K. & Honjo, T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11, 3887–3895 (1992).

3. Agata, Y. et al. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 8, 765–772 (1996).

4. Latchman, Y. et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2, 261–268 (2001).

5. Freeman, G.J. et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192, 1027–1034 (2000).

Cited by 1314 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dendritic Cells Pulsed with HAM/TSP Exosomes Sensitize CD4 T Cells to Enhance HTLV-1 Infection, Induce Helper T-Cell Polarization, and Decrease Cytotoxic T-Cell Response;Viruses;2024-09-10

2. Anti-PD-L1 antibody ASC22 in combination with a histone deacetylase inhibitor chidamide as a “shock and kill” strategy for ART-free virological control: a phase II single-arm study;Signal Transduction and Targeted Therapy;2024-09-09

3. Immune checkpoint inhibitors in infectious disease;Immunological Reviews;2024-09-09

4. Peculiarities of impaired immunoresistance in the formation of post-COVID syndrome and the acute cardiovascular pathology;EMERGENCY MEDICINE;2024-08-29

5. Viral Factors in Modulation of Host Immune Response: A Route to Novel Antiviral Agents and New Therapeutic Approaches;International Journal of Molecular Sciences;2024-08-29